Table 2.
Biomedical activity and application of glycerolipids
| Subclass | Name | Activity | Medical application | Ref. |
|---|---|---|---|---|
| Monoacylglycerol | Monocaprylate | Formation of transient or permanent pores in the membrane | Antimicrobial | Hyldgaard et al., 2012 |
| MonolaurinMoncaprin | Bactericidal activity against H. pylori | Infectious disease | Bergsson et al., 2002 | |
| Monoolein | Antimicrobial activity against S. aureus and E. coli | Antimicrobial | Jumina et al., 2019 | |
| MAG-DHA | Downregulation of NF-kB and upregulation of PTEN | Non-small cell lung cancer | Morin and Fortin, 2017 | |
| Diacylglycerol | Monogalactosyl diacylglycerol | Inhibition of CD31 positive tumor blood vessel growth. | Colon cancer | Maeda et al., 2013 |
| 1,3-Diacylglycerol | Increasing oxidation of fatty acid and suppressing chylomicron formation | Obesity and insulin resistance | Saito et al., 2007 | |
| Triacylglycerol | Medium-chain triglyceride | Suppression of IL-6, iNOS, cyclooxygenase-2 and IL-10 and activation of NF-kB and p38 MAPK pathways | Insulin resistance | Geng et al., 2016 |
| Medium-chain triglyceride | Metabolized to ketone bodies to the brain | Neurological and metabolic disorders | Augustin et al., 2018b | |
| Tricaprilin (AC-1202) | Reducing oxidative damage and improvement of respiration rate in brain | Alzheimer’s disease | Henderson et al., 2009 |